Contents

Anti-Cancer Agents in Medicinal Chemistry, Volume 9 - Number 3

Synthesis of Quinazolines as Tyrosine Kinase Inhibitors

, 9(3): 246 - 275

Sanjay K. Srivastava, Vivek Kumar, Shiv K. Agarwal, Rama Mukherjee and Anand C. Burman


DOI: 10.2174/1871520610909030246




A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells

, 9(3): 276 - 294

S. Brogger Christensen, Dorthe Mondrup Skytte, Samuel R. Denmeade, Craig Dionne, Jesper Vuust Moller, Poul Nissen and John T. Isaacs


DOI: 10.2174/1871520610909030276




Quantification Techniques and Biodistribution of Semiconductor Quantum Dots

, 9(3): 295 - 303

Emilie Pic, Lina Bezdetnaya, Francois Guillemin and Frederic Marchal


DOI: 10.2174/1871520610909030295




Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies

, 9(3): 304 - 325

Lutz F. Tietze and Birgit Krewer


DOI: 10.2174/1871520610909030304




The Management of Metastatic Bone Disease with the Combination of Bisphosphonates and Radiotherapy: From Theory to Clinical Practice

, 9(3): 326 - 335

V. Vassiliou and D. Kardamakis


DOI: 10.2174/1871520610909030326




Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly

, 9(3): 336 - 347

Sylvie Ducki


DOI: 10.2174/1871520610909030336




Mechanisms of Trastuzumab Resistance in Breast Cancer

, 9(3): 348 - 355

Sara M. Tolaney and Ian E. Krop


DOI: 10.2174/1871520610909030348




Current Development of Pd(II) Complexes as Potential Antitumor Agents

, 9(3): 356 - 368

Enjun Gao, Cong Liu, Mingchang Zhu, Huakuan Lin, Qiong Wu and Lei Liu


DOI: 10.2174/1871520610909030356




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science